ACT CAPITAL MANAGEMENT, LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 168 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACT CAPITAL MANAGEMENT, LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$513,000
-38.6%
51,000
-24.4%
0.72%
-19.0%
Q1 2022$836,000
-80.6%
67,500
-64.2%
0.88%
-71.6%
Q4 2021$4,311,000
+8.2%
188,500
+4.7%
3.12%
+51.0%
Q3 2021$3,983,000
+89.1%
180,000
+10.8%
2.06%
+90.8%
Q2 2021$2,106,000162,5001.08%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders